80 related articles for article (PubMed ID: 27532290)
1. Gender specific association of TP53 polymorphisms (EX4 215G>C Arg72Pro, IVS3+40-41ins16, and IVS6+62G>A), with risk of oral cancer subtypes and overall survival of the patients.
Nagam SL; Katta S; Prasad VV
Mol Carcinog; 2017 Mar; 56(3):895-912. PubMed ID: 27532290
[TBL] [Abstract][Full Text] [Related]
2. Differential cancer risk and survival in Indian oral cancer patients with genic region FAS and FASL polymorphisms.
Daripally S; Peddi K
Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Mar; 133(3):315-325. PubMed ID: 34753694
[TBL] [Abstract][Full Text] [Related]
3. Polymorphic variants of drug-metabolizing enzymes alter the risk and survival of oral cancer patients.
Daripally S; Peddi K
3 Biotech; 2020 Dec; 10(12):529. PubMed ID: 33214976
[TBL] [Abstract][Full Text] [Related]
4. Epistatic interaction of Arg72Pro TP53 and -710 C/T VEGFR1 polymorphisms in breast cancer: predisposition and survival.
Rodrigues P; Furriol J; Tormo E; Ballester S; Lluch A; Eroles P
Mol Cell Biochem; 2013 Jul; 379(1-2):181-90. PubMed ID: 23716179
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility to oral cancers with CD95 and CD95L promoter SNPs may vary with the site and gender.
Daripally S; Nallapalle SR; Katta S; Prasad VV
Tumour Biol; 2015 Sep; 36(10):7817-30. PubMed ID: 25944167
[TBL] [Abstract][Full Text] [Related]
6. Association between polymorphisms in apoptotic genes and susceptibility for developing breast cancer in Syrian women.
Lajin B; Alhaj Sakur A; Alachkar A
Breast Cancer Res Treat; 2013 Apr; 138(2):611-9. PubMed ID: 23468244
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation of TP53, polycyclic aromatic hydrocarbon-related exposures, and breast cancer risk among women on Long Island, New York.
Gaudet MM; Gammon MD; Bensen JT; Sagiv SK; Shantakumar S; Teitelbaum SL; Eng SM; Neugut AI; Santella RM
Breast Cancer Res Treat; 2008 Mar; 108(1):93-9. PubMed ID: 17624591
[TBL] [Abstract][Full Text] [Related]
8. Study of the TP53 codon 72 polymorphism in oral cancer and oral potentially malignant disorders in Argentine patients.
Zarate AM; Don J; Secchi D; Carrica A; Galindez Costa F; Panico R; Brusa M; Barra JL; Brunotto M
Tumour Biol; 2017 May; 39(5):1010428317699113. PubMed ID: 28459200
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in cell cycle regulatory genes MDM2 and TP53 are associated with susceptibility to lung cancer.
Zhang X; Miao X; Guo Y; Tan W; Zhou Y; Sun T; Wang Y; Lin D
Hum Mutat; 2006 Jan; 27(1):110-7. PubMed ID: 16287156
[TBL] [Abstract][Full Text] [Related]
10. Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival.
Toffoli G; Biason P; Russo A; De Mattia E; Cecchin E; Hattinger CM; Pasello M; Alberghini M; Ferrari C; Scotlandi K; Picci P; Serra M
Clin Cancer Res; 2009 May; 15(10):3550-6. PubMed ID: 19451596
[TBL] [Abstract][Full Text] [Related]
11. Expression of p53 gene in oral squamous cell carcinoma and its relation with clinical and pathological parameters and prognosis of patients.
Mao C; Lu Y; Lai Q; Xia Y; Yang C
Chin Med Sci J; 1995 Dec; 10(4):199-203. PubMed ID: 8745578
[TBL] [Abstract][Full Text] [Related]
12. Less common genotype variants of TP53 polymorphisms are associated with poor outcome in adult patients with adrenocortical carcinoma.
Heinze B; Herrmann LJ; Fassnacht M; Ronchi CL; Willenberg HS; Quinkler M; Reisch N; Zink M; Allolio B; Hahner S
Eur J Endocrinol; 2014 May; 170(5):707-17. PubMed ID: 24566897
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of tongue and the buccal mucosa represent different biological subentities of the oral carcinoma.
Sathyan KM; Sailasree R; Jayasurya R; Lakshminarayanan K; Abraham T; Nalinakumari KR; Abraham EK; Kannan S
J Cancer Res Clin Oncol; 2006 Sep; 132(9):601-9. PubMed ID: 16767431
[TBL] [Abstract][Full Text] [Related]
14. TP53 and CDKN2a mutations in never-smoker oral tongue squamous cell carcinoma.
Heaton CM; Durr ML; Tetsu O; van Zante A; Wang SJ
Laryngoscope; 2014 Jul; 124(7):E267-73. PubMed ID: 24431303
[TBL] [Abstract][Full Text] [Related]
15. Survival of Danish cancer patients 1943-1987. Buccal cavity and pharynx.
Andersson M; Storm HH
APMIS Suppl; 1993; 33():9-34. PubMed ID: 8512743
[TBL] [Abstract][Full Text] [Related]
16. Combined analysis of pri-miR-34b/c rs4938723 and TP53 Arg72Pro with cervical cancer risk.
Yuan F; Sun R; Chen P; Liang Y; Ni S; Quan Y; Huang J; Zhang L; Gao L
Tumour Biol; 2016 May; 37(5):6267-73. PubMed ID: 26619844
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
[TBL] [Abstract][Full Text] [Related]
18. TP53 Polymorphisms and Colorectal Cancer Risk in Patients with Lynch Syndrome in Taiwan: A Retrospective Cohort Study.
Kamiza AB; Hsieh LL; Tang R; Chien HT; Lai CH; Chiu LL; Lo TP; Hung KY; You JF; Wang WC; Hsiung CA; Yeh CC
PLoS One; 2016; 11(12):e0167354. PubMed ID: 27907203
[TBL] [Abstract][Full Text] [Related]
19. Role of TP53 in the progression of pre-malignant and malignant oral mucosal lesions. A follow-up study of 144 patients.
Ogmundsdóttir HM; Björnsson J; Holbrook WP
J Oral Pathol Med; 2009 Aug; 38(7):565-71. PubMed ID: 19473450
[TBL] [Abstract][Full Text] [Related]
20. Association of the germline TP53 R72P and MDM2 SNP309 variants with breast cancer survival in specific breast tumor subgroups.
van den Broek AJ; Broeks A; Horlings HM; Canisius SV; Braaf LM; Langerød A; Van't Veer LJ; Schmidt MK
Breast Cancer Res Treat; 2011 Nov; 130(2):599-608. PubMed ID: 21667122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
